source
- Opinion: STAT+: Medicare’s new RAPID pathway is a breakthrough for adults. Children are still waiting“The pediatric and orphan pipeline is already the smallest, slowest, and least capitalized segment of the device industry,” writes Kolaleh Eskandanian.STAT · 2mo ago↗ source
- Why we left the FDA: Six former officials share their storiesIn this week's STATus Report, hear from six former FDA officials on why they left the agency.STAT · 2mo ago↗ source
- Odyssey raises more than $300M as biotech goes publicOdyssey Therapeutics pulled together $279 million from its initial public offering, the autoimmune disease drug developer said Thursday night. Odyssey began trading on the Nasdaq on Friday. The bio…Endpoints · 2mo ago↗ source